Clinical Trial Update: The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing lamotrigine dispersible/chewable 100 mg with lamotrigine 100 mg compressed tablet completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lamotrigine compressed tablet 100 mg (lamotrigine)
• Lamotrigine dispersible/chewable tablet 100 mg (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 1 | Status: COMPLETED